Implementing intermittent preventive treatment in infants

The Lancet

Volumn 375, Issue 9709, 2010, Pages 121-

  de Sousa, Alexandra ^a   Salama, Peter ^a   Chopra, Mickey ^a  

^a UNICEF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR;

CHILD CARE; COST EFFECTIVENESS ANALYSIS; DRUG FORMULATION; DRUG SURVEILLANCE PROGRAM; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; IMMUNIZATION; LETTER; MALARIA; MORBIDITY; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PROPHYLAXIS; UNSPECIFIED SIDE EFFECT;

EID: 73449117212     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60047-5     Document Type: Letter

References (4)

1. Aponte J.J., Schellenberg D., Egan A., et al. Intermittent Preventive Treatment for malaria control in African infants: pooled analysis of safety and efficacy in six randomised controlled trials. Lancet 374 (2009) 1533-1542
2. WHO Advisory Committee on Serological Responses to EPI Vaccines in Infants Receiving IPTi. Interim report on IPTi with SP. WHO Internal Report (2006), World Health Organization, Geneva
3. Manzi F., Hutton G., Schellenberg J., et al. From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control. BMC Health Serv Res 8 (2008) 165
4. Hutton G., Schellenberg D., Tediosi F., et al. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bull World Health Organ 87 (2009) 123-129